CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
300453 Jiangxi Sanxin Medtec
- 7.88
- +0.20+2.60%
Market Closed Apr 30 15:00 CST
4.12BMarket Cap18.07P/E (TTM)
7.99High7.69Low100.30KlotVolume7.69Open7.68Pre Close79.03MTurnover2.81%Turnover Ratio18.11P/E (Static)522.40MShares9.0852wk High2.98P/B2.81BFloat Cap5.8052wk Low9.22Limit Up356.52MShs Float15.62Historical High6.14Limit Down3.91%Amplitude1.84Historical Low0.30Dividend TTM7.88Avg Price43.56KlotAsk3.81%Div YieldTTM100Lot Size53.72KlotBid
Jiangxi Sanxin Medtec Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 8.88%360.58M | 15.41%1.5B | 16.38%1.08B | 18.00%686.45M | 21.34%331.16M | -2.69%1.3B | -5.55%929.96M | -11.88%581.75M | -15.11%272.92M | 14.75%1.34B |
| Operating revenue | 8.88%360.58M | 15.41%1.5B | 16.38%1.08B | 18.00%686.45M | 21.34%331.16M | -2.69%1.3B | -5.55%929.96M | -11.88%581.75M | -15.11%272.92M | 14.75%1.34B |
| Other operating revenue | ---- | 5.11%3.85M | ---- | -16.68%1.99M | ---- | 54.16%3.66M | ---- | 60.98%2.38M | ---- | -45.43%2.38M |
| Total operating cost | 9.36%298.17M | 15.03%1.24B | 15.78%893.13M | 17.66%567.97M | 20.54%272.64M | -4.73%1.08B | -5.55%771.38M | -10.14%482.74M | -13.43%226.18M | 15.45%1.13B |
| Operating cost | 9.18%235.74M | 14.63%970.34M | 15.26%703.18M | 15.35%445.56M | 18.54%215.92M | -4.57%846.5M | -5.35%610.06M | -8.71%386.27M | -11.81%182.15M | 16.08%887.03M |
| Operating tax surcharges | 24.23%3.14M | 19.91%12.33M | 14.63%8.82M | 19.33%5.42M | 9.00%2.53M | 0.42%10.28M | -3.39%7.69M | -17.51%4.55M | -14.05%2.32M | -7.94%10.24M |
| Operating expense | -16.55%16.62M | 7.34%84.06M | 17.03%63.74M | 31.47%43.01M | 40.69%19.92M | -12.58%78.31M | -6.26%54.46M | -16.53%32.71M | -18.58%14.16M | 3.38%89.58M |
| Administration expense | 15.94%26.83M | 18.10%107.95M | 9.38%73.17M | 7.12%46.18M | 12.10%23.14M | -11.98%91.41M | -12.36%66.89M | -12.80%43.11M | -19.52%20.64M | 44.78%103.85M |
| Financial expense | 58.83%-406.23K | 33.32%-1.17M | 74.06%-499.23K | 81.72%-464.01K | -75.31%-986.71K | 22.81%-1.76M | -407.02%-1.92M | -1,567.92%-2.54M | -20.12%-562.85K | -198.27%-2.28M |
| -Interest expense (Financial expense) | -48.05%436.53K | -31.08%3.11M | -20.53%3.01M | -17.10%1.99M | -6.72%840.25K | 53.34%4.52M | -9.38%3.79M | -23.10%2.4M | 93.15%900.78K | 41.67%2.95M |
| -Interest Income (Financial expense) | 72.31%-307.58K | 65.14%-2.2M | 65.51%-1.99M | 67.26%-1.69M | 26.34%-1.11M | -46.46%-6.32M | -63.16%-5.78M | -117.55%-5.17M | -23.17%-1.51M | -102.62%-4.32M |
| Research and development | 33.96%16.25M | 25.29%63.98M | 30.80%44.73M | 51.72%28.27M | 62.09%12.13M | 25.02%51.07M | 13.19%34.2M | -7.36%18.63M | -21.07%7.48M | -3.10%40.85M |
| Credit Impairment Loss | 51.56%-883.21K | -191.36%-3.41M | 0.92%-1.77M | 18.95%-969.46K | -22.49%-1.82M | 20.80%-1.17M | 23.98%-1.79M | 44.91%-1.2M | 47.10%-1.49M | 31.88%-1.48M |
| Asset Impairment Loss | -121.35%-86.81K | -1,234.45%-10.58M | 103.71%46.64K | 119.38%117.35K | 7,187.79%406.57K | -253.81%-792.71K | -434.51%-1.26M | -72.32%-605.45K | 98.70%-5.74K | 172.38%515.38K |
| Other net revenue | -26.09%5.04M | -52.39%15.89M | 36.77%17.42M | 44.88%14.3M | -15.42%6.81M | 43.35%33.38M | -6.10%12.73M | 5.55%9.87M | 1,135.44%8.06M | 162.55%23.29M |
| Fair value change income | -49.00%1.1M | -266.36%-2.16M | --7.63M | --5.28M | --2.16M | 10.92%1.3M | ---- | ---- | ---- | --1.17M |
| Invest income | -431.21%-581.55K | 5.66%10.24M | -137.78%-283.48K | -135.75%-159.92K | -110.24%-109.48K | 594.02%9.69M | 92.94%750.27K | 128.49%447.37K | 456.05%1.07M | 404.05%1.4M |
| -Including: Investment income associates | ---- | -95.14%10.72K | ---- | ---- | ---- | 182.51%220.68K | ---- | ---- | ---- | ---267.47K |
| Asset deal income | -173.68%-141.49K | 17.96%190.08K | 39.74%192.04K | 39.74%192.04K | 718.25%192.04K | 2,868.68%161.14K | 2,431.84%137.43K | --137.43K | -82.52%-31.06K | 100.61%5.43K |
| Other revenue | -6.02%5.63M | -10.67%21.62M | -22.10%11.6M | -11.23%9.84M | -29.66%5.99M | 11.62%24.2M | -5.47%14.89M | -5.06%11.08M | 204.66%8.51M | 77.65%21.68M |
| Operating profit | 3.23%67.44M | 8.23%278.85M | 20.60%206.61M | 21.95%132.78M | 19.24%65.33M | 12.01%257.64M | -5.55%171.32M | -17.72%108.88M | -7.81%54.79M | 17.94%230.02M |
| Add:Non operating Income | -72.33%100.54K | 25.37%2.32M | -13.00%2.21M | -74.70%471.62K | -0.23%363.36K | -25.17%1.85M | 282.55%2.54M | 192.20%1.86M | -46.68%364.21K | -60.45%2.47M |
| Less:Non operating expense | 53.21%855.25K | -24.00%5.11M | 37.30%2.74M | 332.29%2.24M | 299.08%558.24K | -2.28%6.72M | -67.20%2M | -89.00%519.07K | -94.98%139.88K | 16.34%6.87M |
| Total profit | 2.38%66.69M | 9.21%276.06M | 19.91%206.08M | 18.85%131.01M | 18.40%65.14M | 12.04%252.77M | -2.33%171.86M | -14.06%110.22M | -4.04%55.02M | 15.48%225.61M |
| Less:Income tax cost | -2.10%7.31M | -3.99%28.36M | 14.50%22.73M | 14.33%15.62M | 1.61%7.47M | 11.39%29.54M | -14.07%19.85M | -19.30%13.67M | 5.38%7.35M | 12.55%26.52M |
| Net profit | 2.96%59.38M | 10.96%247.7M | 20.62%183.34M | 19.50%115.38M | 20.98%57.67M | 12.12%223.23M | -0.56%152.01M | -13.26%96.56M | -5.35%47.67M | 15.88%199.1M |
| Net profit from continuing operation | 2.96%59.38M | 10.96%247.7M | 20.62%183.34M | 19.50%115.38M | 20.98%57.67M | 12.12%223.23M | -0.56%152.01M | -13.26%96.56M | -5.35%47.67M | 15.88%199.1M |
| Less:Minority Profit | 39.44%5.65M | 22.29%20.3M | 45.60%15.43M | 29.06%9.13M | 40.59%4.05M | 14.78%16.6M | 2.54%10.6M | 7.60%7.08M | -1.03%2.88M | -9.04%14.46M |
| Net profit of parent company owners | 0.20%53.73M | 10.05%227.4M | 18.74%167.91M | 18.74%106.25M | 19.72%53.62M | 11.92%206.63M | -0.78%141.41M | -14.57%89.48M | -5.61%44.79M | 18.42%184.63M |
| Earning per share | ||||||||||
| Basic earning per share | -0.39%0.1028 | 10.76%0.4416 | 18.09%0.3232 | 18.07%0.2045 | 19.03%0.1032 | 11.21%0.3987 | -0.80%0.2737 | -14.55%0.1732 | -27.99%0.0867 | -10.33%0.3585 |
| Diluted earning per share | -0.39%0.1028 | 10.64%0.4408 | 18.09%0.3232 | 18.07%0.2045 | 19.03%0.1032 | 11.13%0.3984 | -0.80%0.2737 | -14.55%0.1732 | -27.99%0.0867 | -9.24%0.3585 |
| Other composite income | ||||||||||
| Total composite income | 2.96%59.38M | 10.96%247.7M | 20.62%183.34M | 19.50%115.38M | 20.98%57.67M | 12.12%223.23M | -0.56%152.01M | -13.26%96.56M | -5.35%47.67M | 15.88%199.1M |
| Total composite income of parent company owners | 0.20%53.73M | 10.05%227.4M | 18.74%167.91M | 18.74%106.25M | 19.72%53.62M | 11.92%206.63M | -0.78%141.41M | -14.57%89.48M | -5.61%44.79M | 18.42%184.63M |
| Total composite income of minority owners | 39.44%5.65M | 22.29%20.3M | 45.60%15.43M | 29.06%9.13M | 40.59%4.05M | 14.78%16.6M | 2.54%10.6M | 7.60%7.08M | -1.03%2.88M | -9.04%14.46M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.